- Home
- ALNY vs ANSS Comparison
ALNY vs ANSS Comparison
Compare ALNY & ANSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- ANSS
- Stock Information
- Founded
- ALNY 2002
- ANSS 1970
- Country
- ALNY United States
- ANSS United States
- Employees
- ALNY N/A
- ANSS N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- ANSS Computer Software: Prepackaged Software
- Sector
- ALNY Health Care
- ANSS Technology
- Exchange
- ALNY Nasdaq
- ANSS Nasdaq
- Market Cap
- ALNY 35.0B
- ANSS 28.6B
- IPO Year
- ALNY 2004
- ANSS 1996
- Fundamental
- Price
- ALNY $268.46
- ANSS $316.89
- Analyst Decision
- ALNY Strong Buy
- ANSS Hold
- Analyst Count
- ALNY 23
- ANSS 3
- Target Price
- ALNY $319.27
- ANSS $352.50
- AVG Volume (30 Days)
- ALNY 872.0K
- ANSS 495.2K
- Earning Date
- ALNY 05-01-2025
- ANSS 04-30-2025
- Dividend Yield
- ALNY N/A
- ANSS N/A
- EPS Growth
- ALNY N/A
- ANSS 14.31
- EPS
- ALNY N/A
- ANSS 6.55
- Revenue
- ALNY $2,248,243,000.00
- ANSS $2,544,809,000.00
- Revenue This Year
- ALNY $31.04
- ANSS $11.72
- Revenue Next Year
- ALNY $23.56
- ANSS $10.48
- P/E Ratio
- ALNY N/A
- ANSS $48.43
- Revenue Growth
- ALNY 22.97
- ANSS 12.11
- 52 Week Low
- ALNY $141.98
- ANSS $289.82
- 52 Week High
- ALNY $304.39
- ANSS $363.03
- Technical
- Relative Strength Index (RSI)
- ALNY 55.64
- ANSS 35.25
- Support Level
- ALNY $264.13
- ANSS $318.83
- Resistance Level
- ALNY $300.90
- ANSS $328.88
- Average True Range (ATR)
- ALNY 11.99
- ANSS 5.51
- MACD
- ALNY 2.92
- ANSS 0.37
- Stochastic Oscillator
- ALNY 53.73
- ANSS 18.82
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About ANSS ANSYS Inc.
Ansys is an engineering software company that provides simulation capabilities for structural, fluids, semiconductor power, embedded software, optical, and electromagnetic properties. Ansys employs over 4,000 people and serves over 50,000 customers globally, including those in aerospace defense and automotive.